Kim Blickenstaff - Tandem Diabetes CEO and President and Director

TNDM -- USA Stock  

USD 44.26  3.04  7.38%

Mr. Kim D. Blickenstaff is the President, Chief Executive Officer, and Director of Tandem Diabetes Care, Inc. Prior to joining our company, he served as Chairman and Chief Executive Officer of Biosite Incorporated, or Biosite, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc. in June 2007. Mr. Blickenstaff currently serves as Chairman of Medivation, Inc., and is a member of its audit committee. Mr. Blickenstaff previously served as a director of DexCom, Inc., a provider of glucose monitoring systems, from June 2001 to September 2007
Age: 64  CEO Since 2007  MBA    
Blickenstaff was formerly a certified public accountant and has more than 20 years of experience overseeing the preparation of financial statements. He received a B.A. in Political Science from Loyola University, Chicago, and an M.B.A. from the Graduate School of Business, Loyola University, Chicago. We believe Mr. Blickenstaff brings to our board of directors valuable perspective and experience as our President and Chief Executive Officer, extensive experience at the board level of various healthcare companies, as well as leadership skills, industry experience and knowledge that qualify him to serve as one of our directors.

Kim Blickenstaff Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (25.4) % which means that it has lost $25.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (314.86) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 7 records

CEO Since

Thomas PrescottAlign Technology
Bryan HansonZimmer Biomet Holdings
Namal NawanaSmith Nephew plc
Namal NawanaSmith Nephew plc
Joseph HoganAlign Technology
Michael MahoneyBoston Scientific Corporation
David DvorakZimmer Biomet Holdings

Entity Summary

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California. Tandem Diabetes operates under Medical Devices classification in USA and is traded on NASDAQ General Markets. It employs 574 people.Tandem Diabetes Care (TNDM) is traded on NASDAQ General Markets in USA and employs 574 people.

Tandem Diabetes Care Leadership Team

Brian Hansen, Chief Commercial Officer, Executive Vice President
Fred Cohen, Independent Director
Susan Morrison, Chief Admin. Officer
Lori Gildea, Vice President - Sales
Howard Greene, Independent Director
Christopher Twomey, Independent Director
Henry Anhalt, Independent Director
Edward Cahill, Independent Director
Lonnie Smith, Chairman of the Board
John Cajigas, CFO and Executive VP
Dick Allen, Chairman of the Board
David Berger, General Counsel
Jesse Treu, Independent Director
Richard Valencia, Independent Director
Douglas Roeder, Independent Director
Leigh Vosseller, Senior Vice President - Finance
John Sheridan, COO and Executive VP
Kim Blickenstaff, CEO and President and Director
Robert Anacone, Chief Commercial Officer and Executive VP

Stock Performance Indicators

Current Sentiment - TNDM

Tandem Diabetes Care Investor Sentiment

Most of Macroaxis users are at this time bullish on Tandem Diabetes Care. What is your outlook on investing in Tandem Diabetes Care? Are you bullish or bearish?
98% Bullish
2% Bearish
Currently Active Assets on Macroaxis
Purchased over 300 shares of
2 days ago
Traded for 8.99
Purchased over 20 shares of
2 days ago
Traded for 145.23
Purchased over 20 shares of
2 days ago
Traded for 102.17
Purchased over 300 shares of
2 days ago
Traded for 8.99
Purchased over 20 shares of
2 days ago
Traded for 137.52
Also please take a look at World Market Map. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.